Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival

Abstract

Smoking history, poor performance status, poorly differentiated adenocarcinoma, and high levels of LDH, CEA, and CA 19-9 were shown to be poor prognostic factors, while receiving chemotherapy and zoledronic acid were associated with prolonged survival in gastric cancer patients with bone metastases.